Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuro Watanabe

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 23, 2007
[Early blastic transformation within a year of imatinib treatment in 2 cases of chronic myeloid leukemia]Koji Miyazaki, Shinya Kon, Takuro Watanabe, et al.
Oncogene|April 24, 2002
Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cellsRyouichi Horie, Takuro Watanabe, Yasuyuki Morishita, et al.
Scientific Reports|June 20, 2023
A screening method for cervical myelopathy using machine learning to analyze a drawing behaviorEriku Yamada, Koji Fujita, Takuro Watanabe, et al.
International Journal of Hematology|January 10, 2009
Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantationMayumi Yoshimi, Yasuhito Nannya, Takuro Watanabe, et al.
Internal Medicine (Tokyo, Japan)|May 6, 2021
The Amount of Residual Incretin Regulates the Pancreatic β-cell Function and Glucose HomeostasisTatsuya Kondo, Sayaka Kitano, Nobukazu Miyakawa, et al.
International Journal of Hematology|June 19, 2008
Molecular and cytogenetic response of chronic myelogenous leukemia treated with imatinib mesylate: one institutional experience in JapanYasuhito Nannya, Hiromitsu Yokota, Yumiko Sato, et al.
American Journal of Hematology|July 25, 2006
Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignanciesKumi Oshima, Yoshinobu Kanda, Fumio Nakahara, et al.
Diabetology International|April 1, 2026
Heat shock protein 72 (HSP72) modulates glucagon secretion via JNK inhibition in pancreatic α-cellsTakuro Watanabe, Tatsuya Kondo, Rintaro Yoshizumi, et al.
American Journal of Hematology|October 6, 2007
Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumabShinichi Kako, Yoshinobu Kanda, Kumi Oshima, et al.
Diabetologia|September 9, 2024
An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse modelsTsugumasa Toma, Nobukazu Miyakawa, Yuiichi Arakaki, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 23, 2007
[Early blastic transformation within a year of imatinib treatment in 2 cases of chronic myeloid leukemia]Koji Miyazaki, Shinya Kon, Takuro Watanabe, et al.
Oncogene|April 24, 2002
Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cellsRyouichi Horie, Takuro Watanabe, Yasuyuki Morishita, et al.
Scientific Reports|June 20, 2023
A screening method for cervical myelopathy using machine learning to analyze a drawing behaviorEriku Yamada, Koji Fujita, Takuro Watanabe, et al.
International Journal of Hematology|January 10, 2009
Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantationMayumi Yoshimi, Yasuhito Nannya, Takuro Watanabe, et al.
Internal Medicine (Tokyo, Japan)|May 6, 2021
The Amount of Residual Incretin Regulates the Pancreatic β-cell Function and Glucose HomeostasisTatsuya Kondo, Sayaka Kitano, Nobukazu Miyakawa, et al.
International Journal of Hematology|June 19, 2008
Molecular and cytogenetic response of chronic myelogenous leukemia treated with imatinib mesylate: one institutional experience in JapanYasuhito Nannya, Hiromitsu Yokota, Yumiko Sato, et al.
American Journal of Hematology|July 25, 2006
Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignanciesKumi Oshima, Yoshinobu Kanda, Fumio Nakahara, et al.
Diabetology International|April 1, 2026
Heat shock protein 72 (HSP72) modulates glucagon secretion via JNK inhibition in pancreatic α-cellsTakuro Watanabe, Tatsuya Kondo, Rintaro Yoshizumi, et al.
American Journal of Hematology|October 6, 2007
Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumabShinichi Kako, Yoshinobu Kanda, Kumi Oshima, et al.
Diabetologia|September 9, 2024
An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse modelsTsugumasa Toma, Nobukazu Miyakawa, Yuiichi Arakaki, et al.
Pageof 5